About EIHSX
Eaton Vance Worldwide Health Sciences Fund Class I is an actively managed mutual fund focused on achieving long-term capital growth by investing in health sciences companies worldwide. The fund primarily targets firms involved in the discovery, development, production, or distribution of healthcare-related products and services, including biotechnology, pharmaceuticals, diagnostics, medical equipment and supplies, and managed healthcare. The investment approach emphasizes a diversified, global portfolio, selecting stocks that are considered reasonably valued with strong growth potential, regardless of short-term market movements. This strategy is supported by a team based in Boston and London. The fund benefits from sector tailwinds such as aging demographics, ongoing innovation, and rising global incomes, all contributing to increasing healthcare demand. With a minimum investment threshold set for institutional investors, this class aims to provide exposure across developed and emerging healthcare markets, balancing large-cap leaders with emerging innovators. Eaton Vance Worldwide Health Sciences Fund Class I plays a pivotal role for investors seeking diversified access to global healthcare growth opportunities while navigating sector-specific risks such as regulatory changes, market volatility, and technological advancements.
Fund Family Eaton Vance
Category Health
Performance Rating Average
Risk Rating Below Average
Stock Exchange Nasdaq
Ticker Symbol EIHSX
Share Class Class I
Index MSCI World/Health Care NR
EIHSX had a total return of 11.11% in the past year, including dividends. Since the fund's
inception, the average annual return has been 11.23%.
